Quick Takeaways
- Jake Bauer has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $966,157.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jake Bauer
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Jake Bauer is at least $966,157 dollars as of 09 Apr 2026. Jake Bauer is the Director of Immunovant, Inc. and owns shares of Immunovant, Inc. (IMVT) stock worth about $966.2K.
- Signature
- /s/ Tiago Girao, Attorney-in-Fact for Jake Bauer
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jake Bauer and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Immunovant, Inc. ($966,157).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Jake Bauer
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Director | $966,157 | 07 Apr 2026 | ||
| ARYE | ARYA Sciences Acquisition Corp V | Director | 12 Jul 2021 | |||
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Director | 26 Aug 2025 | |||
| ELVN | Enliven Therapeutics, Inc. | Director | 12 Feb 2026 |
Insider Transactions Reported by Jake Bauer:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.